Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 12, Issue 24
|
pp. 25395–25411
Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC)
Back to article
Figure 1
(1 of 9)
−
100%
+
Figure 1.
The expression of SRD5A3 in various carcinomas.
Transcriptional expression of SRD5A3 in 24 types of cancer (the UALCAN web portal).